The Lancet thelancet.com

[Correspondence] Ebola and health-care providers: the case for preventive vaccination

thelancet.com·18w

[Correspondence] A risky rollback on hepatitis B birth dose in the USA

thelancet.com·18w

[Comment] Announcing the Lancet Commission on Maternal and Newborn Health

thelancet.com·21w

[Articles] Socioeconomic inequalities in cancer survival and access to health care among children and adolescents in China, 2018–24: a prospective nationwide co...

thelancet.com·21w

[Perspectives] In search of rest—Kerry James Marshall: The Histories

thelancet.com·21w

[Comment] National data for global 2030 targets for childhood cancer

thelancet.com·21w

[Articles] Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the he...

thelancet.com·21w

[Articles] Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort study

thelancet.com·22w

[Correspondence] Impact of anti-immigration measures on health

thelancet.com·22w

[Comment] Fetal and maternal outcomes following mpox infection in pregnancy

thelancet.com·22w

[Department of Error] Department of Error

thelancet.com·22w

[World Report] Botswana's HIV services struggle

thelancet.com·22w

[World Report] Sunken treasures: drug discovery in the ocean

thelancet.com·22w

[Comment] Climate change, migration, displacement, and health: past, present, and future

thelancet.com·22w

[Seminar] Prostate cancer

thelancet.com·22w

[Viewpoint] Holding powerful corporations accountable for their health impacts: are corporate rankings effective?

thelancet.com·22w

[Comment] Health equity and displaced people: challenges, progress, and the path forward

thelancet.com·22w

[Correspondence] Gender-based violence and displacement in Darfur's war

thelancet.com·23w

[The Lancet Commissions] The Lancet Commission on improving population health post-COVID-19

thelancet.com·23w

[Articles] Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 t...

thelancet.com·23w

Log in to enable infinite scrolling